Find out more about PEP & RCA screening
Our PEP profiles are built with a major focus on RCAs, which include spouses, partners, and children, to give a more accurate insight into the risk of who you’re doing business with.
Learn moreAs part of their customer due diligence obligations, banks and financial institutions must establish whether their clients are politically exposed persons (PEP) and at risk of being involved in financial crimes, like money laundering. Politically exposed persons fall into several categories. While many are politicians or hold governmental positions, others may qualify for PEP status because of their connection or proximity to another individual. In this context, PEPs may also be known as relatives and close associates (RCA).
Relatives and close associates, sometimes referred to as ‘PEPs by association,’ are a type of politically exposed person who shares a family or friendship connection to a PEP. As outlined in FATF guidance, that connection may be a direct family relation or a connection through marriage (or civil partnership). Alternatively, it may be a social or professional association. The list of people who may qualify as RCAs includes:
RCAs may also be joint beneficial owners of an entity in which a PEP has an interest or the sole beneficial owners of an entity set up for the benefit of a PEP.
Financial institutions must monitor RCAs as part of their AML/CFT screening process because friends and family tend to be involved in or drawn into financial crimes perpetrated by others. To deal with the risk posed by RCAs, screening should take place at the start of the business relationship and periodically throughout the relationship via ongoing monitoring. Ongoing monitoring is important as financial institutions must be able to react quickly should the risk exposure of a PEP or RCA change.
Our PEP profiles are built with a major focus on RCAs, which include spouses, partners, and children, to give a more accurate insight into the risk of who you’re doing business with.
Learn more
Originally published 14 October 2019, updated 24 September 2024
Disclaimer: This is for general information only. The information presented does not constitute legal advice. ComplyAdvantage accepts no responsibility for any information contained herein and disclaims and excludes any liability in respect of the contents or for action taken based on this information.
Copyright © 2024 IVXS UK Limited (trading as ComplyAdvantage).